curium pharma

Private

—N/Ahttps://curiumpharma.com

Last Round

Private Equity

12/2/2020

Last Round Size

$1.4B

Est. Valuation

$3.6B

Total Funding Raised

$1.4B

Company Overview

Developer and manufacturer of radiopharmaceutical products for diagnosing and treating cancer, heart, brain, and bone diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

curium pharma Comps

Related companies by embedding similarity.

Company	Similarity	Domain
SpaceX	0%	—
Tesla	0%	—
Competitor 1	XX%	—
Competitor 2	XX%	—

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

curium pharma Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	12/2/2020
Debt	10/13/2020
M&A	1/27/2017

View all Funding Rounds

curium pharma Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

curium pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about curium pharma's valuation, stock price, and market status.

Firmographic Details

Headquarters—

Year Founded2017

Last Funding12/2/2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.